146830-44-6

Upstream product

• 146830-36-6 (+)-(1S,4R,4aS,5R,8S,8aR)-5-Acetoxy-1,4,4a,5,8,8a-hexahydro-8-hydroxy-endo-1,4-methanonaphthalene 
• 146830-38-8 (1S,4R,4aS,5R,8S,8aR)-8-Methoxymethoxy-1,4,4a,5,8,8a-hexahydro-1,4-methano-naphthalen-5-ol 
• 146830-42-4 (1S,4R,4aS,5S,6R,7S,8R,8aR)-6,7,8-Tris-methoxymethoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4-methano-naphthalen-5-ol 
• 146830-41-3 C₁₇H₂₇BrO₇ 
• 146830-37-7 Acetic acid (1S,4R,4aS,5R,8S,8aR)-8-methoxymethoxy-1,4,4a,5,8,8a-hexahydro-1,4-methano-naphthalen-5-yl ester 
• 146830-39-9 C₁₃H₁₇BrO₃ 
• 146830-40-2 C₁₃H₁₉BrO₅ 
• 678197-26-7 tricyclo[6.2.1.0^2,7]undeca-4,9-diene-3,6-diol 
• 51175-59-8 norbornenoquinone 
• 351884-99-6 (1S,2S,3R,4S,5S,7R)-7-Benzyloxymethyl-2,3,4-tris-methoxymethoxy-6,8-dioxa-bicyclo[3.2.1]octane 
• 351884-97-4 Benzoic acid (1S,2S,4S,5S,6S,7R)-7-benzyloxymethyl-3,8,9-trioxa-tricyclo[4.2.1.0^2,4]non-5-yl ester 
• 351885-08-0 (1R,2S,3R,4S,5R,7S)-7-Iodomethyl-2,3,4-tris-methoxymethoxy-6,8-dioxa-bicyclo[3.2.1]octane 
• 351885-05-7 ((1S,2S,3R,4S,5S,7R)-2,3,4-Tris-methoxymethoxy-6,8-dioxa-bicyclo[3.2.1]oct-7-yl)-methanol 
• 351884-98-5 (1R,2S,3R,4S,5S,7R)-7-Benzyloxymethyl-6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol 

Downstream Products

• 123355-00-0 (1R,2R,3S,4R)-1,2,3,4-tetra-O-acetylconduritol C 
• 123238-09-5 (1R,2R,3S,4R)-cyclohex-5-ene-1,2,3,4-tetrol 
• 146830-45-7 (1R,4R,5S,6R)-4,5,6-Tris-methoxymethoxy-cyclohex-2-enol 

Relevant academic research and scientific papers

Enantiodivergent Route to Conduritol C via Lipase-mediated Asymmetrization

Enantiodivergent route to conduritol C 13 has been developed by utilizing the optically pure sterting material 3 obtained from the meso-diol 2 by lipase-mediated asymmetrization.

A New Convergent Route to Conduritols A-F from a Common Chiral Building Block

(matrix presented) A diastereocontrolled route to conduritols A-F has been developed starting from a common chiral building block containing an oxabicyclo-[3.2.1]octane framework.